Search Results

Your search for Matthew Lunning, DO, and James O. Armitage, MD matches 2 pages

Showing 1 - 2

By Caroline Helwick / August 25, 2018 / Pan Pacific Lymphoma Conference 2018

First James O. Armitage Clinical Investigator Award Presented in Maui

Matthew S. Davids, MD, MMSc, is the recipient of the first James O. Armitage Clinical Investigator Award, presented at the 2018 Pan Pacific Lymphoma Conference in July in Maui. Dr. Davids is Director of the Lymphoma BioBank and Assistant Professor of Medicine at Dana-Farber Cancer Institute and...

lymphoma

By Matthew Lunning, DO, and James O. Armitage, MD / November 15, 2013

Standardizing the Interpretation of PET Scans: An INR Equivalent

Since its introduction, the positron-emission tomography (PET) scan has shown great potential to improve our ability to care for patients with lymphoma. By demonstrating which masses seen on a computed tomography (CT) scan represent viable tumor, and by identifying viable tumor in places that were...

Nov

Today In Oncology

Search Results

Your search for Matthew Lunning, DO, and James O. Armitage, MD matches 2 pages

First James O. Armitage Clinical Investigator Award Presented in Maui

Standardizing the Interpretation of PET Scans: An INR Equivalent

Novel EGFR Inhibitor Firmonertinib Shows Activity in Rare Subtype of NSCLC

Outcomes of Immune Checkpoint Inhibitor Treatment for Cancer in Black vs White Patients in the U.S. VHA System

Pooled Analysis of Long-Term Outcomes With Nivolumab With or Without Ipilimumab in Advanced Melanoma

Neuro-Oncology Guidelines Reveal How AI Could Improve Brain Cancer Diagnosis Monitoring and Treatment

Firefighters May Be Exposed to Chemicals Associated With Breast Cancer